ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

ICU IN Cup

0.10
0.00 (0.00%)
14 Jun 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
IN Cup LSE:ICU London Ordinary Share GB00B06C2Z82 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 0.10 0.00 01:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
0 0 N/A 0

Trading Statement

31/01/2007 7:03am

UK Regulatory


RNS Number:4115Q
In Cup Plus PLC
31 January 2007

In Cup Plus Plc ("In Cup Plus" or the "Company)



Trading Update



Highlights

*       100 Xen-550 machines invoiced during the year ended 31 December 2006
(2005:41 machines)

*       Two major contracts signed

  -16 machines were installed in November 2006 under a contract with a leading
  global pharmaceutical company

  -a contract for 66 machines has been signed with a "Big 4" global professional
  services company, all of which are expected to be installed by Q1 2007

*       Forecast machine installations for 2007 of 200 machines (+100% on 2006)

Trading Update



The directors believe that 2006 has been a landmark year for In Cup Plus and its
trading subsidiary E Break Limited. The directors believe that the sales and
marketing strategy is working and is creating a sustainable platform for future
growth and is pleased that the level of interest in the Company's products
remains strong.



Sales of the Company's core machine, the In Cup Plus Xen-550, for the 12 months
to 31 December 2006 totalled 100 machines (2005: 41 machines), slightly lower
than the 107 machines previously forecast. The loss for the year is expected to
be in the region of #965,000 (2005: loss of #1,003,000).



The directors are delighted with two major contract wins for the In Cup Plus
beverage system. The first, with a leading global pharmaceutical company
involved the installation of 16 machines in November 2006. There is the
potential for further installations at the same location. The second, with a
city of London based "Big 4" global professional services company was won
through an extensive trial process followed by a competitive tender. The
contract is for a total of 66 machines throughout the company's London HQ
complex, 4 of which were installed in December 2006 with the remainder expected
to be installed by the end of Q1 2007, with the further potential of additional
orders to their regional offices throughout the UK. Based on current ingredient
usage patterns it is estimated that the ingredient revenue generated from these
contracts together with the current total installed machine base will be in the
order of #1,500,000 over the next three years.



The directors believe that the Company's potential is beginning to be
demonstrated by the growing monthly revenues from ingredient sales and that 2007
will be an exciting year of growth and development. These two recent contract
wins are both with major global companies and the Board believes are a
recognition of the potential of the Xen-550 machine. The Company is forecasting
200 machine installations for the 2007 year as a whole, a substantial increase
on that achieved in 2006. With orders of 65 machines in January the directors
are confident of meeting its forecast for 2007.



Martin Colenutt, Chairman of In Cup Plus PLC comments:

"It is acknowledged that the group sales have initially been slower than
originally anticipated. However, the recent high profile multiple orders are
endorsing the unique benefits of the In Cup Plus beverage system and we expect
to be able to capitalise on these achievements. The 2007 confirmed order book is
strong and we are looking forward to a good year. As machine numbers in the
marketplace grow, the regular ingredients income is becoming a strong core
revenue line."

Enquiries:
In Cup Plus
Martin Colenutt                                   0870 7461 8888

Deloitte Corporate Finance
Jonathan Hinton                                   020 7936 3000
James Lewis



The directors of In Cup Plus accept responsibility for the information contained
in this announcement. To the best of the knowledge and belief of the directors
of In Cup Plus (who have taken all reasonable care to ensure that such is the
case) the information contained in this announcement is in accordance with the
facts and does not omit anything likely to affect the import of such
information.




                      This information is provided by RNS
            The company news service from the London Stock Exchange
END

TSTOKKKQOBKDPDN

1 Year In Cup Plus Chart

1 Year In Cup Plus Chart

1 Month In Cup Plus Chart

1 Month In Cup Plus Chart